Omega’s trans-Atlantic bridge

As Omega Funds has moved its center of gravity from Switzerland to the U.S., it has wanted to keep its access to European deals that could turn into big successes in the U.S. like Micromet Inc. and BioVex Inc., both acquired by Amgen Inc. (NASDAQ:AMGN). Omega’s solution was to form a strategic alliance with NeoMed Management.

The European venture firm, based in Geneva and Oslo, will provide advice and assist in investing the Omega V fund, which raised over $300 million. Omega will share a portion of its management fee, and NeoMed will be eligible for a carried interest on any future returns...